Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL186567 | 0.94 | LMNA (0.43) | — | |
| Phosphoric Acid SCHEMBL8930444 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL6396341 | 0.94 | LMNA (0.43) | — | |
| Phosphoric Acid SCHEMBL1963974 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL23529389 | 0.89 | — | — | |
| Phosphoric Acid SCHEMBL15794069 | 0.89 | — | — | |
| Phosphoric Acid SCHEMBL28760857 | 0.89 | — | — | |
| Phosphoric Acid SCHEMBL10899073 | 0.89 | LMNA (0.40) | — | |
| Phosphoric Acid SCHEMBL525116 | 0.89 | LMNA (0.40) | — | |
| Phosphoric Acid SCHEMBL7629564 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0483304-B1 | METHOD OF INACTIVATION OF VIRAL AND BACTERIAL BLOOD CONTAMINANTS | BAXTER INT (US) | 2003-02-19 | — | — | EP | disclosed |
| EP-0633786-B1 | METHOD OF INACTIVATION OF VIRAL, PARASITIC AND BACTERIAL BLOOD CONTAMINANTS | BAXTER INT (US) | 2001-08-01 | — | — | EP | disclosed |
| US-6187572-B1 | DECONTAMINATING BLOOD AND CELL CULTURES BY MIXING WITH A CHEMICAL RADIATION SENSITIZER WHICH DOES NOT BIND TO THE MEMBRANE, FREEZING OR FREEZE-DRYING THE MIXTURE, THEN EXPOSING TO ELECTROMAGNETIC RADIATION | BAXTER INTERNATIONAL INC. | 2001-02-13 | — | — | US | disclosed |
| US-5587490-A | BINDING TO A PSORALEN COMPOUND | CREDIT MANAGERS ASSOCIATION OF CALIFORNIA (US) | 1996-12-24 | — | — | US | disclosed |
| EP-0483304-A4 | METHOD OF INACTIVATION OF VIRAL AND BACTERIAL BLOOD CONTAMINANTS | CRYOPHARM CORP (US) | 1995-08-23 | — | — | EP | disclosed |
| US-5418130-A | Phosphonium or ammonium halo-psoralen | CRYOPHARM CORPORATION (US) | 1995-05-23 | — | — | US | disclosed |
| EP-0633786-A4 | METHOD OF INACTIVATION OF VIRAL AND BACTERIAL BLOOD CONTAMINANTS. | CRYOPHARM CORP (US) | 1995-04-19 | — | — | EP | disclosed |
| WO-1995002324-A1 | METHOD OF INACTIVATION OF VIRAL AND BACTERIAL BLOOD CONTAMINANTS | CRYOPHARM CORPORATION (US) | 1995-01-26 | — | — | WO | disclosed |
| EP-0633786-A1 | METHOD OF INACTIVATION OF VIRAL AND BACTERIAL BLOOD CONTAMINANTS | BAXTER INTERNATIONAL INC. (US) | 1995-01-18 | — | — | EP | disclosed |
| WO-1993014791-A2 | METHOD OF INACTIVATION OF VIRAL AND BACTERIAL BLOOD CONTAMINANTS | CRYOPHARM CORPORATION (US) | 1993-08-05 | — | — | WO | disclosed |
| EP-0483304-A1 | METHOD OF INACTIVATION OF VIRAL AND BACTERIAL BLOOD CONTAMINANTS | BAXTER INTERNATIONAL INC. (US) | 1992-05-06 | — | — | EP | disclosed |
| WO-1991016060-A1 | METHOD OF INACTIVATION OF VIRAL AND BACTERIAL BLOOD CONTAMINANTS | CRYOPHARM CORPORATION (US) | 1991-10-31 | — | — | WO | disclosed |